Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Read more

GSK Pharmaceuticals' EBITDA in India FY 2015-2020

Published by Statista Research Department, Oct 16, 2020
In fiscal year 2020, GlaxoSmithKline Pharmaceuticals Limited in India had almost 6.6 billion Indian rupees as earnings before interest, tax, depreciation and amortization. This was an increase compared to the previous fiscal year's 6.31 billion rupees worth EBITDA.

EBITDA of GSK Pharmaceuticals Limited in India from financial year 2015 to 2020 (in billion Indian rupees)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account
$39 $59 per month *
in the first 12 months
View for free
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Additional Information

© Statista 2021

Show source

Show detailed source information?
Register for free
Already a member?
Log in
Source

Show sources information
Show publisher information

Release date

June 2020

Region

India

Survey time period

FY 2015 to FY 2020

Supplementary notes

*Earnings before interest, tax, depreciation and amortization (EBITDA) for the year 2017-18, year 2016-17, year 2015-16 and 15 months ended March 2015 were as per Ind Accounting Standards.

One Indian rupee is equal to 0.012 euros and 0.014 U.S. dollars (as of September 2020).

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "GlaxoSmithKline Pharmaceuticals Limited India"

The most important statistics
The most important statistics
The most important statistics

Further Content: You might find this interesting as well

Statistics

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Menu